fluorodeoxyglucose f18 has been researched along with Down Syndrome in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (26.67) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Alcolea, D; Altuna, M; Annus, T; Barroeta, I; Belbin, O; Benejam, B; Blesa, R; Camacho, V; Carmona-Iragui, M; Clarimón, J; Estellés, T; Fernández, S; Fortea, J; Giménez, S; González-Ortiz, S; Holland, AJ; Illán-Gala, I; Lehmann, S; Lleó, A; Montal, V; Muñoz, L; Osorio, RS; Pegueroles, J; Valldeneu, S; Videla, L; Videla, S; Vilaplana, E; Wilson, LR; Zaman, SH | 1 |
Andrews, RD; Brewer, J; Lukic, AS; Matthews, DC; Mobley, WC; Ness, S; Pennington, C; Rafii, MS; Rissman, RA; Strother, SC; Wernick, MN | 1 |
Barnhart, TE; Betthauser, TJ; Bulova, PD; Christian, BT; Cohen, AD; Devenny, DA; Handen, BL; Hartley, SL; Johnson, SC; Klunk, WE; Lao, PJ; Lopresti, BJ; Mathis, CA; Mihaila, I; Murali, D; Price, JC; Stone, CK; Tudorascu, DL; Tumuluru, RV | 1 |
Bandy, D; Belden, C; Chen, K; Fleisher, AS; Jacobson, S; Liebsack, C; Liu, X; Luo, J; Malek-Ahmadi, M; Powell, J; Protas, H; Reiman, EM; Rogers, J; Roontiva, A; Sabbagh, MN; Thiyyagura, P | 1 |
Alkire, MT; Cotman, CW; Haier, RJ; Head, E; Lott, IT; Uncapher, MR; White, NS | 1 |
Balogh, E; Emri, M; Esik, O; Kollár, J; Lengyel, Z; Oláh, E; Sikula, J; Szikszai, E; Trón, L | 2 |
Creasey, H; Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Rapoport, SI; Schapiro, MB | 1 |
Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Haxby, JV; Horwitz, B; Mangot, D; Mentis, MJ; Pietrini, P; Schapiro, MB; Simon, EW | 1 |
Comblain, A; Rondal, JA | 1 |
Friedland, RP; Grady, CL; Haxby, JV; Herscovitch, P; Kumar, A; Moore, AM; Rapoport, SI; Schapiro, MB; White, B | 1 |
Grady, CL; Horwitz, B; Rapoport, SI; Schapiro, MB | 1 |
Cutler, NR; Davies, P; Haxby, JV; Heston, LL; Schapiro, MB | 1 |
Cutler, NR | 1 |
Duara, R; Grady, CL; Haxby, JV; Larson, SM; Moore, A; Rapoport, SI; Schapiro, MB; Schlageter, NL; Sundaram, M; White, B | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Down Syndrome
Article | Year |
---|---|
NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain; Brain Chemistry; Cognition; Dementia; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neurotransmitter Agents; Parasympathetic Nervous System; Psychological Tests; Tomography, Emission-Computed | 1985 |
1 trial(s) available for fluorodeoxyglucose f18 and Down Syndrome
Article | Year |
---|---|
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.
Topics: Adult; Aged; Alzheimer Disease; Down Syndrome; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Reference Values; Reproducibility of Results; Temporal Lobe; Tomography, Emission-Computed | 2003 |
13 other study(ies) available for fluorodeoxyglucose f18 and Down Syndrome
Article | Year |
---|---|
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Down Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofilament Proteins; Positron-Emission Tomography; Prevalence; Spain; tau Proteins; United Kingdom | 2020 |
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Topics: Adult; Amyloid; Apolipoproteins E; Cerebellum; Cognition Disorders; Cohort Studies; Down Syndrome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; tau Proteins | 2017 |
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Down Syndrome; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; United States | 2018 |
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Topics: Adult; Alzheimer Disease; Aniline Compounds; Brain; Down Syndrome; Emergency Services, Psychiatric; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2015 |
Pattern of increased cerebral FDG uptake in Down syndrome patients.
Topics: Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Telencephalon | 2006 |
NIH Conference. Brain imaging: aging and dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Processes; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Wechsler Scales | 1984 |
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Topics: Acoustic Stimulation; Adult; Age Factors; Alzheimer Disease; Auditory Perception; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Motion Pictures; Parietal Lobe; Photic Stimulation; Risk Factors; Temporal Lobe; Tomography, Emission-Computed; Visual Perception | 1997 |
Language in ageing persons with Down syndrome.
Topics: Adolescent; Adult; Age Factors; Brain; Cohort Studies; Cross-Sectional Studies; Down Syndrome; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Language Development Disorders; Language Tests; Longitudinal Studies; Male; Middle Aged; Tomography, Emission-Computed | 2002 |
[Cerebral glucose metabolism in Down syndrome using positron emission tomography].
Topics: Adolescent; Adult; Brain; Child; Child, Preschool; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Regional cerebral glucose metabolism is normal in young adults with Down syndrome.
Topics: Adult; Aging; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Reference Values; Tomography, Emission-Computed | 1990 |
Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilization.
Topics: Adult; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Down Syndrome; Female; Fluorodeoxyglucose F18; Humans; Male; Tomography, Emission-Computed | 1990 |
Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
Topics: Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Oxygen Consumption; Radioisotopes; Tomography, Emission-Computed | 1986 |
Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
Topics: Adolescent; Adult; Aging; Brain; Cognition; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1987 |